The demand for clarity from National Institutes of Health Director Dr. Jayanta “Jay” Bhattacharya comes on the heels of a contentious Capitol Hill appearance in February.

Dr. Tara Gregory says women remain underrepresented in studies and encourages participation in clinical trials and consultation with trusted medical providers.

Stem cells are gaining attention for their potential to treat leukemia, certain solid tumor cancers, and inherited metabolic ...

Alphamab Oncology (stock code: 9966.HK) announced that the first patient has been successfully dosed in the phase I clinical study (study code: JSKN027-101) of JSKN027, an independently developed inno ...

In a phase 2b clinical trial, an investigational oral therapy called PrimeC was found to be safe and well tolerated in people ...

NS002 demonstrated significantly faster time to the critical 100 pg/mL epinephrine threshold compared to EpiPen®, with a ...

ClinCapture announces AI-powered clinical trial build tech that automates study configuration, and advances intelligent ...

CLEVELAND, Ohio — A shift toward personalized treatment for breast cancer, ways to help patients live longer without their ...

Rich Pelt, senior director of Global Regulatory Sciences at Pfizer gives tips for navigating the rapidly changing regulatory ...

Emerald Clinical Trials, a leading global clinical research organization (CRO), today announced it has been named a winner of ...

Amgen Inc. (NASDAQ:AMGN) is a biotechnology company that discovers, develops, and manufactures medicines to treat serious ...

Affinity Technologies (NASDAQ:BIAF) announced on March 10, 2026, the launch of a large longitudinal clinical study involving 2,000 patients to evaluate the performance of its CyPath® Lung technology ...